PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9365827-6 1997 The ANP-evoked reduction in MAP was not affected in haloperidol- or phentolamine-treated rats (-8.8 +/- 2.3 and -10.5 +/- 2.4%, respectively; both p < 0.005 vs. vehicle) but was abolished in propranolol-treated rats (+3.2 +/- 1.3%; p = ns vs. vehicle). Propranolol 194-205 natriuretic peptide A Rattus norvegicus 4-7 18191303-14 2008 Propranolol and tetrodotoxin significantly (p<0.01) inhibited 55% and 60%, respectively, the toxin-induced ANP release. Propranolol 0-11 natriuretic peptide A Rattus norvegicus 110-113 9365827-7 1997 The ANP-induced increase in hematocrit was slightly attenuated in haloperidol-, phentolamine-, and propranolol-treated rats (7.5 +/- 0.7, 7.3 +/- 0.8, and 6.0 +/- 1%, respectively). Propranolol 99-110 natriuretic peptide A Rattus norvegicus 4-7 1531103-10 1992 Propranolol abolished the release of ANP by Iso but not that induced by stretching. Propranolol 0-11 natriuretic peptide A Rattus norvegicus 37-40 7653628-10 1995 Prop partially inhibited the Iso-evoked increases in ANF and FN mRNA, completely prevented the Iso-induced changes in TGF-beta 1 and SERCA mRNA, but had no effect on the Iso-stimulated changes in SK and PNK gene expression. Propranolol 0-4 natriuretic peptide A Rattus norvegicus 53-56 7731062-5 1994 The significant diacylglycerol increase at 10(-10) M ANF, in the presence of propranolol, a potent inhibitor of phosphatidate phosphatase which can hydrolyse phosphatidate to give diacylglycerol, suggested a direct involvement of PC-PLC. Propranolol 77-88 natriuretic peptide A Rattus norvegicus 53-56 8028022-3 1994 Activation of alpha 1-adrenergic receptors by norepinephrine (in the presence of propranolol) increased the rate of ANP secretion approximately two-fold (EC50 = 0.32 microM). Propranolol 81-92 natriuretic peptide A Rattus norvegicus 116-119 1980994-9 1990 Conversely, propranolol treatment resulted in lower plasma ANP levels in rats with high sodium intake. Propranolol 12-23 natriuretic peptide A Rattus norvegicus 59-62 1980994-11 1990 The results suggest that dietary sodium intake is an important determinant of the response of atrial-specific granule number and plasma ANP levels following beta-adrenoceptor blockade with propranolol. Propranolol 189-200 natriuretic peptide A Rattus norvegicus 136-139 2961012-3 1987 The response to EPI was completely blocked by equimolar propranolol but not by phenoxybenzamine suggesting that, at least in this system, the adrenergic control of ANF secretion is mediated by beta-adrenergic receptors. Propranolol 56-67 natriuretic peptide A Rattus norvegicus 164-167 2526588-12 1989 Phentolamine (1.3 microM) and propranolol (0.1 microM) each reduced peak hypoxia-induced (0% O2) ANF release to 333 and 310%, respectively, whereas atropine sulfate (15 microM) had no inhibitory effect. Propranolol 30-41 natriuretic peptide A Rattus norvegicus 97-100 2932194-8 1985 The relaxant action of synthetic ANF on the renal vessels was seen in the presence of ouabain (1 mM), propranolol (1 microM), phentolamine (1 microM), atropine (1 microM) and felodipine (1 nM). Propranolol 102-113 natriuretic peptide A Rattus norvegicus 33-36